Momenta Pharmaceuticals, Inc. (MNTA)

CAPS Rating:

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

View All Commentary (MNTA)

Recs

2

Avatar KatWoman50 (51.97) Submitted: 11/06/07 3:04 PM : Start Price: $6.02 MNTA Score: 99.25

Attempting to catch a falling knife. Momenta has a lot more in the pipeline than just M-enoxaparin and should bounce when the over-reaction is finished. 160M cash should tide them over for awhile even without further investment.

Report this Post Replies: 1 | Reply

Avatar KatWoman50 (51.97) Submitted: 3/28/08 12:42 PM

Recs: 0 | Rec This

should have pulled the trigger in real life

Report this Post Reply

Momenta Pharmaceuticals, Inc. (MNTA)

2

Featured Broker Partners